SLC16A1 and small cell lung carcinoma: Research on small-cell lung cancer has found that knocking down MCT4 is necessary to make tumors sensitive to the MCT1 inhibitor AZD396, indicating that the compensatory effect of MCT4 inhibits the antitumor effect of MCT1 inhibitors [87].